Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram.
Ayse Irem YasinMahmut UluganyanZehra Sucuoglu IsleyenAtakan TopcuAbdallah Tm ShbairMelih SimsekMehmet BesirogluYeliz Emine ErsoyHacı Mehmet TürkMesut SekerPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2024)
This is the first study evaluating effects of ribociclib treatment on cardiac rhythm with Holter ECG. The findings suggested ribociclib has a low risk of causing early cardiotoxicity.